Related Experiment Video
Updated: May 28, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
Tafenoquine: A Breakthrough Option for Babesiosis Treatment
Dongxue Ma1, Mo Zhou2, Shinuo Cao2
1Department of Veterinary Medicine, Agriculture College, Yanbian University, Yanji 133000, China.
Abstract:
Babesiosis is a zoonosis caused by protozoan parasites of the genus Babesia. It has a worldwide distribution and affects many kinds of mammals, principally domestic animals and humans. Because there are no safe and effective vaccines available, the treatment and control for babesiosis continues to involve the use of chemotherapeutics. For years, only a few drugs have been used for clinical treatment, namely atovaquone plus azithromycin or clindamycin plus quinine for human, and imidocarb dipropionate and diminazene aceturate for domestic animals. Although screening and developing alternative drugs are continuously pursued, only a few drugs have been prospected to have clinical applications. Of these, tafenoquine has shown wide and potent antibabesial activity, offering a new option to control babesiosis. This article aims to present the current clinical therapeutic strategies for babesiosis and their limitations, as well as the prospect of tafenoquine as a promising drug to treat babesiosis.
More Related Videos
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
Related Concept Videos
Anthelminthic Agents
Malaria
Antiprotozoal Agents
Toxoplasmosis
American Trypanosomiasis
Symbiosis